CORNISHWAY GROUP PRACTICE
FORUM HEALTH, SIMONSWAY, WYTHENSHAWE, MANCHESTER
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 25 | 31 | 80.6% | |
| HF 4 | 2011 | 24 | 28 | 85.7% | |
| HF 4 | 2012 | 24 | 29 | 82.8% | |
| HF 4 | 2013 | 28 | 32 | 87.5% | |
| HF004 | 2014 | 3 | 3 | 100.0% | |
| HF004 | 2015 | 3 | 4 | 75.0% | |
| HF004 | 2016 | 3 | 4 | 75.0% | |
| HF004 | 2017 | 3 | 3 | 100.0% | |
| HF004 | 2018 | 21 | 24 | 87.5% | |
| HF004 | 2019 | 23 | 24 | 95.8% | |
| HF004 | 2020 | 22 | 23 | 95.7% | |
| HF006 | 2021 | 37 | 41 | 90.2% | |
| HF006 | 2022 | 33 | 33 | 100.0% | |
| HF006 | 2023 | 37 | 38 | 97.4% |
